GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Poly Medicure Ltd (NSE:POLYMED) » Definitions » YoY EBITDA Growth

Poly Medicure (NSE:POLYMED) YoY EBITDA Growth : 21.22% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Poly Medicure YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Poly Medicure's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 21.22%.

Poly Medicure's EBITDA per Share for the three months ended in Mar. 2024 was ₹11.66.


Poly Medicure YoY EBITDA Growth Historical Data

The historical data trend for Poly Medicure's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poly Medicure YoY EBITDA Growth Chart

Poly Medicure Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.48 26.46 -0.14 19.92 38.25

Poly Medicure Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.00 96.33 33.94 25.45 21.22

Poly Medicure YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Poly Medicure's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (A: Mar. 2024 )
=(EBITDA per Share (A: Mar. 2024 )-EBITDA per Share (A: Mar. 2023 ))/ | EBITDA per Share (A: Mar. 2023 ) |
=(43.694-31.605)/ | 31.605 |
=38.25 %

Poly Medicure's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(11.66-9.619)/ | 9.619 |
=21.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Poly Medicure YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Poly Medicure's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Poly Medicure (NSE:POLYMED) Business Description

Traded in Other Exchanges
Address
Okhla Industrial Estate, 232-B, 3rd Floor, Phase III, New Delhi, IND, 110020
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.

Poly Medicure (NSE:POLYMED) Headlines

No Headlines